Menu

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Publications

Assessing the Impact of Data Diversity on Background Incidence Rates of Adverse Events of Special Interest: The Component Strategy from the COVID-19 Vaccine Monitoring Project

G. ROBERTO, D. MESSINA, C. DURÁN, J. RIERA-ARNAU, P. GARCIA, M. MARTÍN-PÉREZ, O. PAOLETTI, C. BISSACCO, F. VILLALOBOS, J. CARRERAS, A. MIRA, P. SOUVEREIN, F. RIEFOLO, O. KLUNGEL, M. STURKENBOOM and R. GINI
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
A Comparison of Self-Controlled Study Designs in an Analysis of COVID-19 Vaccines and Myocarditis Using Five European Databases

A. SCHULTZE, I. MARTIN, D. MESSINA, S. BOTS, S. BELITSER, J. CARRERAS, E. CORRECHER-MARTINEZ, A. URCHUEGUÍA-FORNES, M. MARTÍN-PÉREZ, P. GARCIA, F. VILLALOBOS, M. PALLEJÀ-MILLÁN, C. BISSACCO, E. SEGUNDO, P. SOUVEREIN, F. RIEFOLO, C. DURÁN, R. GINI, M. STURKENBOOM, O. KLUNGEL and I. DOUGLAS
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
Cohort Event Monitoring of COVID-19 Vaccine Safety Using Patient-Reported Outcomes in Lactating Women

E. MAISONNEUVE, F. CICCIMARRA, N. LUXI, C. BELLITTO, M. RAETHKE, F. VAN HUNSEL, T. LIEBER, E. MULDER, F. RIEFOLO, F. VILLALOBOS, N. THURIN, F. MARQUES, K. MORTON, F. O'SHAUGHNESSY, S. SONDERLICHOVÁ, A. FARCAS, J. GIELE-ESHUIS, S. SIISKONEN, D. BAUD, M. STURKENBOOM, A. PANCHAUD and G. TRIFIRÒ
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
Interim Results from the VAC4EU Post-Authorization Safety Study (PASS) Among Recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) Vaccine in Europe

D. WEIBEL, C. DE LUISE, A. ROYO, O. RYAN, T. VAZ, J. AGUADO, J. MARSAL, X. MARTINEZ, R. WEINRIB, N. YEFIMENKO, E. PALÀ, B. POBLADOR-PLOU, A. GIMENO-MIGUEL, A. SANTOS-MEJÍAS, E. MARCONI, E. BARBIERI, L. STONA, T. LYSEN, D. ROY, G. HYERACI, A. GIRARDI, A. LUPATTELLI, A. DESALEGN, F. VILLALOBOS, C. BISSACCO, K. KENDRICK, R. GARG, H. RUBINO, M. STURKENBOOM and A. ARANA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
Cohort Event Monitoring of COVID-19 Vaccine Safety Using Patient-Reported Outcomes in Pregnant Women

E. MAISONNEUVE, F. CICCIMARRA, N. LUXI, C. BELLITTO, M. RAETHKE, F. VAN HUNSEL, T. LIEBER, E. MULDER, F. RIEFOLO, F. VILLALOBOS, N. THURIN, F. MARQUES, K. MORTON, F. O'SHAUGHNESSY, S. SONDERLICHOVÁ, A. FARCAS, S. SIISKONEN, D. BAUD, J. GIELE-ESHUIS, M. STURKENBOOM, G. TRIFIRÒ and A. PANCHAUD
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:

Board of Trustees

Collaborators

Accreditations